hrp0084p3-748 | Diabetes | ESPE2015

Health Literacy of Caregivers of Children with Type 1 Diabetes: A Pilot Study on Impact on Glycaemic Control in an Arabic-Speaking Population

Al-Abdulrazzaq Dalia , Alhaddad Muneera , Al-fadhli Amani , Alyousef Amna , Altararwa Abeer , Albasari Iman

Introduction: Health literacy has been linked to poorer diabetes control and outcomes. Caregivers with poor health literacy may fail to comprehend various elements of diabetes education leading to poor glycaemic control of their children. No studies to date had investigated the link between caregivers’ health literacy and their children’s glycaemic control in an Arabic-speaking population.Objectives and hypothesis: Our aim is to study the link ...

hrp0089p3-p073 | Diabetes & Insulin P3 | ESPE2018

Effects of Diabetes Mellitus Type-1 on Vitamin D Status Among Children

Alshareef Abeer

Introduction: Vitamin D defciency is a common health concern among all children world wide.together with the rapidly increased prevalence of diabetes mellitus\.This study was conducted to determine if diabetes is associated with increased risk of vitamin D deficiencydy examination the influences of diabetes effecting status on specific patients disease characteristics in regards to vitamin D level among children from saudi arabia.Methods: All retrospecti...

hrp0094p2-51 | Adrenals and HPA Axis | ESPE2021

A Rare Cause of Hyponatremia in a Child with Hirschsprung Disease Operated with an Ileostomy

Alassaf Abeer ,

Background and Objectives: Pseudohypoaldosteronism (PHA) is a rare condition characterized by hyponatremia, hyperkalemia, metabolic acidosis and high plasma aldosterone level. Pseudohypoaldosteronism secondary to gastrointestinal losses is rare in the pediatric population. We present a case with secondary pseudohypoaldosteronism due to excessive gastrointestinal losses through ileostomy.Methods: A 1.5 year-old-male child...

hrp0097p1-138 | Multisystem Endocrine Disorders | ESPE2023

An isolated hyperchlorhidrosis in a a patient with CA12 mutation.

Alkhalaf Abeer , Alfaraidi Haifa

Hyponatremia is a common electrolytes disorder in children. It can result from sodium chloride losses through GI, the kidneys, or in the sweat. Sodium chloride loss in the sweat can be caused by many different etiologies as cystic fibrosis, malnutrition, metabolic diseases, dermatological diseases and endocrine diseases. We are reporting a 6 months old boy, medically free, who had recurrent admissions to the PICU as a case of hyponatremic dehydration, with a sodium level of 11...

hrp0084p3-673 | Bone | ESPE2015

Successful Treatment of Severe Hypercalcemia in an Infant with Williams Syndrome Using a Single Infusion of Pamidronate Followed by Low Calcium Diet

Odeh Rasha , Albaramki Jumana , Alassaf Abeer

Background: 15% of patients with Williams syndrome develop hypercalcemia that is described as mild and transient. There are, however, reported cases with severe hypercalcemia that did not respond to traditional therapy. Pamidronate was used in the treatment of this condition, and was successful in the few reported cases in the literature.Case presentation: We report a 9 month old female who presented with failure to thrive, polyuria and polydipsia. She h...

hrp0097p1-275 | Fat, Metabolism and Obesity | ESPE2023

Child with AR sitosterolemia with no hematological manifestations.

Alkhalaf Abeer , Aldubayee Mohammed , Alzaben Abdullah

Sitosterolemia is an autosomal recessive disorder affecting lipid metabolism which is characterized by decreased biliary excretion and increased absorption of plant sterols and cholesterol, leading to significantlyelevated serum levels of plant sterols. Approximately 80 homozygous or compound heterozygous variants in adenosine triphosphate-binding cassette subfamily G genes (ABCG5/ABCG8) genes have been described in patients with genetically confirmed sitosterolemia. Clinicall...

hrp0089p2-p257 | Growth & Syndromes P2 | ESPE2018

Clinical Effectiveness and Cost-Effectiveness of Somatropin Treatment for Short Children in Egypt: Analysis of 1-Year Data

Ibrahim Amany , Atef Abeer , Badawy Nora , Helmy Eatemad

Recombinant human growth hormone (rhGH) is approved for short stature associated with growth hormone deficiency (GHD), idiopathic short stature (ISS), Turner syndrome (TS), multiple pituitary hormone deficiencies (MPHD), Silver Russell syndrome (SRS) and being born small for gestational age non syndromic (SGA). Objectives: To assess the clinical effectiveness and cost-effectiveness of rhGH in children with GHD, TS and those born SGA. Methods: ...

hrp0086p2-p861 | Syndromes: Mechanisms and Management P2 | ESPE2016

The Effect of Iron Intervention on the Anthropometric Parameters: Pilot Study among Egyptian Preschool Children with Iron Deficiency Anemia

Ibrahim Amany , Atef Abeer , Magdy Rania , Farag Mohamed

Background: Iron deficiency anemia (IDA) causes detrimental effects on physical growth which is attributed to poor appetite, altered endocrinologic profile and neurotransmitter metabolism consequent to iron deficiency.Objective and hypotheses: To investigate the iron status of preschool children with IDA and its association with the degree of growth retardation at presentation, and to detect the effect of iron supplementation on growth velocity (GV) over...

hrp0084p1-43 | Diabetes | ESPE2015

Evaluation of Median Nerve in Children with Type1 Diabetes using Ultrasonographic Imaging and Electrophysiology

Elbarbary Nancy , Maghawry Abeer , ElHilaly Rana , Refaat Rania

Background: Diabetic neuropathy is recognised as the most common clinical picture of nervous system disorders caused by DM and is considered the most common type of neuropathies.Objective and hypotheses: To evaluate the relationship between the sonographically measured cross-sectional area (CSA) of the median nerve and nerve conduction study (NCS) in children with type1 diabetes (T1DM) complaining of DPN.Method: 40 children withT1D...

hrp0097p1-132 | Growth and Syndromes | ESPE2023

One-year growth response and cost-effectiveness to Human recombinant growth hormone in girls with Turner Syndrome: Results from a large Egyptian retrospective study

Ibrahim Amany , Atef Abeer , Badawi Nora , Yassin Sahar , Helmy Eatemad

FDA licensed the use of human recombinant growth hormone (hGH) in girls with Turner Syndrome (TS) in 1997 as short stature is a consistent feature of this syndrome.Objective: we aimed to assess our 1-year experience of treating short girls with TS, to calculate their growth velocity, to analyze the patients’ characteristics and to investigate the possible factors that might affect their height gain.Me...